Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors.

Breast cancer research and treatment - 1 Sept 2007

Graves Kristi D, Peshkin Beth N, Halbert Chanita H, DeMarco Tiffani A, Isaacs Claudine, Schwartz Marc D

Abstract excerpt

BACKGROUND: Women affected with breast cancer who carry a BRCA1 or BRCA2 (BRCA1/2) mutation are at risk of developing contralateral breast cancer. To reduce the risk of contralateral breast cancer, some patients opt for prophylactic surgery of the unaffected breast (contralateral prophylactic mastectomy, CPM) in addition to mastectomy of the affected breast. METHODS: We conducted the present study to determine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Genetic Counseling

Share to Genetic Testing

Share to Mastectomy

Share to Odds Ratio

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 17066320
DOI: 10.1007/s10549-006-9423-5
PMCID: PMC3060055

Genes

CPM
BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors.PMID 17066320Read ↗

Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result.Semantic proximity Read ↗

Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing.Semantic proximity Read ↗

Survival Outcomes in Women with Unilateral, Triple-Negative, Breast Cancer Correlated with Contralateral Prophylactic Mastectomy.Semantic proximity Read ↗

Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients.Semantic proximity Read ↗

Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.Semantic proximity Read ↗

Negative Genetic Testing Does Not Deter Contralateral Prophylactic Mastectomy in Younger Patients with Greater Family Histories of Breast Cancer.Semantic proximity Read ↗

Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.Semantic proximity Read ↗

Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis.Semantic proximity Read ↗

Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations.Semantic proximity Read ↗

Differences Among a Modern Cohort of BRCA Mutation Carriers Choosing Bilateral Prophylactic Mastectomies Compared to Breast Surveillance.Semantic proximity Read ↗

Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.Semantic proximity Read ↗

Preoperative risk assessment among women undergoing bilateral prophylactic mastectomy for cancer risk reduction.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.